{"data":[{"accessionNo":"0000935836-26-000398","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":"45674E208","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"LYTTON-KAMBARA FOUNDATION","reportingCik":null,"personType":"IN","sharesOwned":1056513,"percentOfClass":9.99,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000935836-26-000398","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":"45674E208","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"LYTTON LAURENCE W","reportingCik":null,"personType":"IN","sharesOwned":1056513,"percentOfClass":9.99,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001682638-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":"45674E208","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-27","reportingPerson":"EMILY FAIRBAIRN","reportingCik":"0001682638","personType":"IN","sharesOwned":215431,"percentOfClass":2.2,"filedAt":"2026-05-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001682638-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":"45674E208","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-27","reportingPerson":"Malcom Fairbairn","reportingCik":null,"personType":"IN","sharesOwned":205626,"percentOfClass":2.1,"filedAt":"2026-05-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001682638-26-000008","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":"45674E208","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-27","reportingPerson":"Malcom and Emily Fairbairn 2010 CRUT","reportingCik":null,"personType":"OO","sharesOwned":202582,"percentOfClass":2.1,"filedAt":"2026-05-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000935836-26-000141","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-22","reportingPerson":"LYTTON LAURENCE W","reportingCik":null,"personType":"IN","sharesOwned":984031,"percentOfClass":9.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000935836-26-000141","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-22","reportingPerson":"LYTTON-KAMBARA FOUNDATION","reportingCik":null,"personType":"IN","sharesOwned":984031,"percentOfClass":9.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001172661-26-001177","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8bio, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":966381,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001172661-26-001177","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8bio, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":966381,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001172661-26-001177","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8bio, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":966381,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000038777-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8bio, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Franklin Advisers, Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":914531,"percentOfClass":9.4,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000038777-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8bio, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Franklin Resources, Inc.","reportingCik":null,"personType":"HC,CO","sharesOwned":914531,"percentOfClass":9.4,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000038777-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8bio, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Rupert H. Johnson, Jr.","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000038777-26-000028","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8bio, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Charles B. Johnson","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001682638-26-000002","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-22","reportingPerson":"EMILY FAIRBAIRN","reportingCik":"0001682638","personType":"IN","sharesOwned":733293,"percentOfClass":7.5,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001682638-26-000002","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-22","reportingPerson":"Malcom Fairbairn","reportingCik":null,"personType":"IN","sharesOwned":727681,"percentOfClass":7.5,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001682638-26-000002","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-22","reportingPerson":"Malcom and Emily Fairbairn 2010 CRUT","reportingCik":null,"personType":"OO","sharesOwned":724637,"percentOfClass":7.4,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001404574-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-22","reportingPerson":"Ari Zweiman","reportingCik":null,"personType":"IN","sharesOwned":770445,"percentOfClass":7.86,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001404574-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-22","reportingPerson":"683 Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":770445,"percentOfClass":7.86,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001404574-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-22","reportingPerson":"683 Capital Partners, LP","reportingCik":null,"personType":"PN","sharesOwned":770445,"percentOfClass":7.86,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Advisors GP, LLC","reportingCik":"0001813844","personType":"PN","sharesOwned":391357,"percentOfClass":4,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Fletcher Aaron G.L.","reportingCik":"0001789490","personType":"PN","sharesOwned":391357,"percentOfClass":4,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Capital Management, LP","reportingCik":"0001813845","personType":"PN","sharesOwned":391357,"percentOfClass":4,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Cavu Management, LP","reportingCik":"0001813270","personType":"PN","sharesOwned":286664,"percentOfClass":2.9,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Cavu Advisors, LLC","reportingCik":"0001813310","personType":"PN","sharesOwned":286664,"percentOfClass":2.9,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Kreis Leslie W.","reportingCik":"0001813316","personType":"IN","sharesOwned":286664,"percentOfClass":2.9,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Equity Partners III, LP","reportingCik":"0001831976","personType":"PN","sharesOwned":163343,"percentOfClass":1.7,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Fund III QP, LP","reportingCik":"0001791916","personType":"PN","sharesOwned":124253,"percentOfClass":1.3,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Bios Equity Partners II, LP","reportingCik":"0001813313","personType":"PN","sharesOwned":123321,"percentOfClass":1.3,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Bios Clinical Opportunity Fund, LP","reportingCik":"0001988639","personType":"PN","sharesOwned":104693,"percentOfClass":1.1,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Bios Equity COF, LP","reportingCik":"0002000747","personType":"PN","sharesOwned":104693,"percentOfClass":1.1,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Fund II QP, LP","reportingCik":"0001716869","personType":"PN","sharesOwned":62554,"percentOfClass":0.6,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Incysus Co-Invest I, LP","reportingCik":"0001740029","personType":"PN","sharesOwned":33247,"percentOfClass":0.3,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Fund II, LP","reportingCik":"0001714576","personType":"PN","sharesOwned":19147,"percentOfClass":0.2,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Fund III, LP","reportingCik":"0001791917","personType":"PN","sharesOwned":19024,"percentOfClass":0.2,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Fund III NT, LP","reportingCik":"0001791910","personType":"PN","sharesOwned":20066,"percentOfClass":0.2,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BIOS Fund II NT, LP","reportingCik":"0001728851","personType":"PN","sharesOwned":8373,"percentOfClass":0.1,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"Bios Equity Partners, LP","reportingCik":"0001813314","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0001714576-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001740279","issuerName":"IN8BIO, INC.","ticker":"INAB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-22","reportingPerson":"BP Directors, LP","reportingCik":"0001813311","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000935836-25-000732","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-19","reportingPerson":"Stonepine Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1007990,"percentOfClass":9.9,"filedAt":"2025-12-22","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000935836-25-000732","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-19","reportingPerson":"Stonepine Capital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1007990,"percentOfClass":9.9,"filedAt":"2025-12-22","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000935836-25-000732","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-19","reportingPerson":"Stonepine GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1007990,"percentOfClass":9.9,"filedAt":"2025-12-22","canonicalUrl":"https://xoomar.com/markets/stocks/inab"},{"accessionNo":"0000935836-25-000732","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001740279","issuerName":"IN8BIO, Inc.","ticker":"INAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-19","reportingPerson":"Jon M. Plexico","reportingCik":null,"personType":"HC,IN","sharesOwned":1007990,"percentOfClass":9.9,"filedAt":"2025-12-22","canonicalUrl":"https://xoomar.com/markets/stocks/inab"}],"updatedAt":"2026-11-05T15:20:41.515Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/inab","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}